Orgenesis Statistics
Total Valuation
Orgenesis has a market cap or net worth of 5.87 million. The enterprise value is 24.02 million.
| Market Cap | 5.87M |
| Enterprise Value | 24.02M |
Important Dates
The last earnings date was Friday, March 20, 2026.
| Earnings Date | Mar 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Orgenesis has 9.80 million shares outstanding.
| Current Share Class | 9.80M |
| Shares Outstanding | 9.80M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +21.34% |
| Owned by Insiders (%) | 17.46% |
| Owned by Institutions (%) | 0.52% |
| Float | 8.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.67 |
| PB Ratio | -0.16 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.50 |
| EV / Sales | 23.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.39 |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.05 |
| Interest Coverage | -6.96 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -204.48% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 101.74% |
| Weighted Average Cost of Capital (WACC) | 18.37% |
| Revenue Per Employee | 13,442 |
| Profits Per Employee | -625,519 |
| Employee Count | 77 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Orgenesis has paid 97,000 in taxes.
| Income Tax | 97,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.04% in the last 52 weeks. The beta is 3.81, so Orgenesis's price volatility has been higher than the market average.
| Beta (5Y) | 3.81 |
| 52-Week Price Change | -76.04% |
| 50-Day Moving Average | 0.45 |
| 200-Day Moving Average | 0.65 |
| Relative Strength Index (RSI) | 56.42 |
| Average Volume (20 Days) | 1,442 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.92 |
Income Statement
In the last 12 months, Orgenesis had revenue of 1.04 million and -48.17 million in losses. Loss per share was -11.44.
| Revenue | 1.04M |
| Gross Profit | -893,000 |
| Operating Income | -26.02M |
| Pretax Income | -48.92M |
| Net Income | -48.17M |
| EBITDA | -23.93M |
| EBIT | -26.02M |
| Loss Per Share | -11.44 |
Balance Sheet
The company has 78,000 in cash and 18.26 million in debt, with a net cash position of -18.18 million or -1.86 per share.
| Cash & Cash Equivalents | 78,000 |
| Total Debt | 18.26M |
| Net Cash | -18.18M |
| Net Cash Per Share | -1.86 |
| Equity (Book Value) | -37.53M |
| Book Value Per Share | -7.25 |
| Working Capital | -26.16M |
Cash Flow
In the last 12 months, operating cash flow was -17.08 million and capital expenditures -263,000, giving a free cash flow of -17.34 million.
| Operating Cash Flow | -17.08M |
| Capital Expenditures | -263,000 |
| Depreciation & Amortization | 2.09M |
| Net Borrowing | 5.91M |
| Free Cash Flow | -17.34M |
| FCF Per Share | -1.77 |
Margins
| Gross Margin | -86.28% |
| Operating Margin | -2,513.53% |
| Pretax Margin | -4,726.18% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Orgenesis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -45.16% |
| Shareholder Yield | -45.16% |
| Earnings Yield | -820.54% |
| FCF Yield | -295.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 25, 2024. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
Orgenesis has an Altman Z-Score of -318.66 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -318.66 |
| Piotroski F-Score | 4 |